Dulaglutide can also cause side effects, including gastrointestinal symptoms and a boxed warning regarding thyroid C-cell tumors, and should only be used under the guidance of a licensed healthcare provider
Whether you are exploring Semaglutide (Ozempic/Wegovy) or Tirzepatide (Mounjaro/Zepbound), our team provides personalized treatment plans based on your medical history, weight-loss goals, and provider evaluation
These medications can be helpful and work really well, but theyre not magicand theyre definitely not for everyone. So, what should you consider if youre interested in taking GLP-1s postpartum
Elafibranor, an agonist of the peroxisome proliferator-activated receptor- and -, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening
Published clinical guidelines from organizations including the American Society of Metabolic and Bariatric Surgery and the Obesity Medicine Association have identified GLP-1 receptor agonists as appropriate pharmacological interventions in patients with a BMI of 30 or above (classified as obesity), or BMI of 27 or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea - the same criteria framework used by the FDA in evaluating GLP-1 medications for their obesity management indications